CHICAGO — Sometimes logic and anecdotal information just can't connect the dots. Such was the case with the long-awaited CLOSURE 1 randomized controlled clinical trial results to evaluate the safety and efficacy of NMT Medical's (Boston) STARFlex septal closure system that were reported this week at the American Heart Association (AHA; Dallas) 2010 Scientific Sessions. (Medical Device Daily) Read More
